** Shares in Belgian pharmaceutical ingredients supplier
Fagron FAGRO.BR up 5.4% after the company reported a 1.5%
turnover beat for its Q3 urn:newsml:reuters.com:*:nFWN26V0W2
** KBC Securities says that in Europe the company delivers
on its return-to-growth promise and inches closer to the 2.7% FY
growth goal, which the brokerage now deems achievable
** According to KBC, Fagron remains well-positioned for
sustainable growth in Latin America, both organically and
through its high-potential acquisitions
** The brokerage points to strong mid- to long-term growth
perspectives in the United States
** ING says it considers the outcome of Q3 update positive,
adding it should help the share price
** The stock is at the top of Euronext Next 150 .N150
Index
(michal.aleksandrowicz@tr.com)